Literature DB >> 21616432

Bland embolization in the treatment of hepatic adenomas: preliminary experience.

Ajita Deodhar1, Lynn A Brody, Anne M Covey, Karen T Brown, George I Getrajdman.   

Abstract

The study presents preliminary, retrospective experience with bland embolization for hepatic adenomas (HAs) with the use of tris-acryl gelatin microspheres. Eight patients underwent bland embolization for biopsy-proven HAs. A biopsy specimen was taken from only one lesion when multiple lesions were present. Seventeen embolizations were performed for abdominal pain, active bleeding, or prophylaxis against bleeding. Five patients underwent multiple procedures. Technical success rate was 100%. Median follow-up was 24 months (range, 10-40 mo). No growth was observed at follow-up in any treated lesion, and many lesions (13 of 16) regressed. Bland embolization may be safely used for treatment of abdominal pain and bleeding from HAs.
Copyright © 2011 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21616432     DOI: 10.1016/j.jvir.2011.02.027

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  14 in total

1.  Interreader and inter-test agreement in assessing treatment response following transarterial embolization for hepatocellular carcinoma.

Authors:  Olivio F Donati; Richard Kinh Gian Do; Andreas M Hötker; Seth S Katz; Junting Zheng; Chaya S Moskowitz; Christopher Beattie; Karen T Brown
Journal:  Eur Radiol       Date:  2015-04-08       Impact factor: 5.315

2.  Giant Hepatic Adenoma in a 12-Year-Old Girl.

Authors:  Hemant Kumar Singh; Shraddha Patkar; A M Polnaya; Mukta Ramadwar; Mahesh Goel
Journal:  J Gastrointest Cancer       Date:  2019-03

3.  Changes in the management of benign liver tumours: an analysis of 285 patients.

Authors:  James J Mezhir; Lindsay T Fourman; Richard K Do; Brian Denton; Peter J Allen; Michael I D'Angelica; Ronald P DeMatteo; Yuman Fong; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2012-09-21       Impact factor: 3.647

4.  Transarterial embolization of hypervascular tumors using trisacryl gelatin microspheres (Embosphere): a prospective multicenter clinical trial in Japan.

Authors:  Keigo Osuga; Yasuo Nakajima; Miyuki Sone; Yasuaki Arai; Yoshihiro Nambu; Shinichi Hori
Journal:  Jpn J Radiol       Date:  2016-03-10       Impact factor: 2.374

5.  LATE SURGICAL TREATMENT FOR SPONTANEOUS RUPTURE OF HEPATOCELLULAR ADENOMA: CASE REPORT.

Authors:  Luis Eduardo Veras Pinto; João Paulo Ribeiro Silva; Gustavo Coêlho Rêgo; José Huygens Parente Garcia
Journal:  Arq Bras Cir Dig       Date:  2015 Nov-Dec

6.  Management of hepatocellular adenoma: comparison of resection, embolization and observation.

Authors:  Ami M Karkar; Laura H Tang; Nilesh D Kashikar; Mithat Gonen; Stephen B Solomon; Ronald P Dematteo; Michael I D' Angelica; Camilo Correa-Gallego; William R Jarnagin; Yuman Fong; George I Getrajdman; Peter Allen; T Peter Kingham
Journal:  HPB (Oxford)       Date:  2012-10-09       Impact factor: 3.647

7.  Regression of hepatocellular adenomas with strict dietary therapy in patients with glycogen storage disease type I.

Authors:  Richard D Beegle; Laurie M Brown; David A Weinstein
Journal:  JIMD Rep       Date:  2014-10-12

Review 8.  Hepatocellular adenoma: when and how to treat? Update of current evidence.

Authors:  Maarten G Thomeer; Mirelle Broker; Joanne Verheij; Michael Doukas; Turkan Terkivatan; Diederick Bijdevaate; Robert A De Man; Adriaan Moelker; Jan N IJzermans
Journal:  Therap Adv Gastroenterol       Date:  2016-09-28       Impact factor: 4.409

9.  Changing epidemiology of hepatocellular adenoma in the United States: review of the literature.

Authors:  Charissa Y Chang; Juan C Hernandez-Prera; Sasan Roayaie; Myron Schwartz; Swan N Thung
Journal:  Int J Hepatol       Date:  2013-02-24

Review 10.  New insights in the management of Hepatocellular Adenoma.

Authors:  Anne J Klompenhouwer; Robert A de Man; Marco Dioguardi Burgio; Valerie Vilgrain; Jessica Zucman-Rossi; Jan N M Ijzermans
Journal:  Liver Int       Date:  2020-06-11       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.